Ameritas Investment Partners, Inc. Evolus, Inc. Transaction History
Ameritas Investment Partners, Inc.
- $2.86 Billion
- Q1 2024
A detailed history of Ameritas Investment Partners, Inc. transactions in Evolus, Inc. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 4,084 shares of EOLS stock, worth $44,311. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,084
Previous 4,084
-0.0%
Holding current value
$44,311
Previous $43,000
32.56%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding EOLS
# of Institutions
173Shares Held
47MCall Options Held
720KPut Options Held
532K-
Perceptive Advisors LLC New York, NY5.75MShares$62.4 Million1.69% of portfolio
-
Tang Capital Management LLC San Diego, CA4.15MShares$45 Million7.07% of portfolio
-
Black Rock Inc. New York, NY3.26MShares$35.4 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.04MShares$33 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.91MShares$31.6 Million2.62% of portfolio
About Evolus, Inc.
- Ticker EOLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 56,094,800
- Market Cap $609M
- Description
- Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...